BETHESDA, MD--(BUSINESS WIRE)--Sucampo Pharmaceuticals, Inc. (NASDAQ:SCMP) today announced that its Board of Directors has approved four actions to strengthen Sucampo: implementing a holding company structure; appointing Sachiko Kuno, Ph.D., to the Board of Directors; promoting Jan Smilek as Chief Financial Officer; and, approving a stock buy-back of up to $10 million. The business operations of the company and its subsidiaries will not change as a result of the new holding company structure.
